Jan 30, 2018 - Companies In The News are:
Jan 30, 2018 - Sanofi (SNY) to acquire Ablynx for EUR 3.9 billion to expand its late stage pipeline and strengthen rare blood disorder growth platform.
Jan 29, 2018 - With AbbVie (ABBV) surpassing expectations in the fourth quarter, here's a look at a few important takeaways from the company's conference call.
Jan 26, 2018 - AbbVie's (ABBV) Q4 earnings top estimates with revenues marginally beating the same. Sales of the company's lead marketed drug, Humira, also rise year over year.
Jan 24, 2018 - Sanofi's leap into an undeniably big market could face challenges as treatment evolves.
Jan 23, 2018 - Does Celgene's (CELG) decision to acquire Juno signal the revival of biotech M&A activity after a slow 2017?
Jan 21, 2018 - Both big pharma stocks have growth drivers. But both also come with baggage.
Jan 19, 2018 - The Zacks Analyst Blog Highlights: Johnson & Johnson, AbbVie, Amgen, Novo-Nordisk and Zoetis
Jan 18, 2018 - We present four large cap drug companies, which are expected to repeat their last year's industry beating performance in 2018.
Jan 17, 2018 - The outlook is complicated for this big pharma stock.